Tag: drug companies
-
Opinion pieces for and against pharmacy benefit manager reforms in the news
By Melissa Patrick Kentucky Health News The Kentucky General Assembly has worked for years to pass laws aimed at reining in the practices of pharmacy benefit managers, saying they create...
-
Drug prices keep rising, with no end in sight
By Trudy Lieberman Rural Health News Service Recently a tweet from Lauren Sausser, a fine health reporter I know in South Carolina, caught my eye. “Crazy drug prices became personal....
-
Conway gets $24 million from Purdue Pharma to settle Oxycontin claim, $15.5 million from J & J subsidiary in Risperdal case
Purdue Pharma will pay the state $24 million to settle a lawsuit that claimed the drug maker “illegally misrepresented and/or concealed the highly addictive nature of OxyContin and encouraged doctors...
-
Louisville’s PharMerica is still a defendant in federal cases in which big drug makers have paid billions in fines
Abbott Laboratories has paid billions, and Amgen Inc. has paid millions, in fines for offering “rebates” or “kickbacks” to get pharmacy companies to increase their prescriptions of drugs in nursing...
-
Rogers, other drug-caucus chair file bill to reverse FDA’s approval of new painkiller; competing company has alternative
Illustration from PainAndDepression.com U.S. Reps. Hal Rogers of Somerset and Stephen Lynch of Massachusetts have introduced a bill to withdraw federal approval of a new formulation of hydrocodone that is...
-
More than $32 million from settlements with drug makers will finance expanded substance-abuse treatment in Kentucky
By Melissa Patrick and Al Cross Kentucky Health News Kentucky will receive more than $32 million as a result of lawsuit settlements with two pharmaceutical companies, and top state officials...
-
FDA changes painkiller labels to warn expectant mothers, after 2,500% growth in number of Ky. babies born addicted to drugs
The U.S. Food and Drug Administration (FDA) announced Tuesday drug-safety labeling changes and new post-market study requirements for all extended-release and long-acting opioids, and Kentucky political leaders applauded these measures to...